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tein expressed on the surface of almost all cells in the
body, but at particularly high levels on neurons. PrPC has
been shown to be essential for the development of prion
disease, and Prnpo/o mice, which lack PrPC, are resistant
to scrapie (Büeler et al., 1993). 
The physiological function of PrPC is unknown, and
may be linked to prion pathophysiology. If PrPC was an
enzyme, one could speculate that conversion to PrPSc
may trigger changes in its activity or substrate specificity,
which – by a loss-of-function or gain-of-function – may
conceivably contribute to prion pathology. The latter line
of thought gained considerable momentum when it was
shown that synthetic peptides encompassing the octare-
peat region of PrPC bind copper (Hornshaw et al., 1995)
and a PrPC-copper complex was also described in vivo
(Brown et al., 1997a; Stockel et al., 1998). 
PrPC was hypothesized to act as an antioxidant (Brown
et al., 1999; Sayre et al., 1999; Wong et al., 1999), since
cultured cells lacking PrPC were reported to display an al-
tered response to oxidative stress in vitro (Brown et al.,
1997b, 1998) and in vivo (Klamt et al., 2001; Wong et al.,
2001; Brown et al., 2002) and show a higher rate of apop-
tosis upon growth-factor withdrawal (Kuwahara et al.,
1999). It was then reported that Prnpo/o mice exhibit de-
creased activity of the Cu2 +/Zn2 +-superoxide dismutase
(SOD1; Brown et al., 1997b), a major radical scavenger
enzyme located in the cytosol and other subcellular com-
partments (Kira et al., 2002). If this was correct, PrPC
might contribute indirectly to SOD1 activity, or may be an
SOD itself (Brown et al., 1999; Wong et al., 2000), whose
reduced availability (thanks to conversion into PrPSc) may
reduce scavenging of reactive oxygen species and con-
tribute to neurodegeneration in prion diseases. 
The data discussed above may provide a simple and
attractive theory of prion pathogenesis, but have been
challenged in various ways. Firstly, the results favoring an
SOD-like activity of PrPC were mainly generated with re-
combinant bacterially expressed proteins – which may or
may not reproduce the activity of PrPC in vivo. Secondly
and more worryingly, Waggoner and colleagues found no
correlation between brain copper content, level of PrPC
expression, and cuproenzyme activity in mice overex-
pressing or lacking PrPC (2000). Thirdly, it is now estab-
lished that unintentional overexpression of the PrPC-ho-
mologue Dpl in some PrPC-deficient mouse strains and
cell lines accounts for at least some of the alterations de-
scribed above (Moore et al., 1999; Behrens and Aguzzi,
2002). 
The contradictory reports on whether PrPC exhibits
SOD activity in vivo prompted us to analyze this question
in defined genetic mouse models. Using two independ-
Biol. Chem., Vol. 384, pp.1279 – 1285, September 2003 · Copyright © by Walter de Gruyter · Berlin · New York
Gregor Huttera, Frank L. Heppnera,* and
Adriano Aguzzi*
Institute of Neuropathology, Schmelzbergstrasse 12,
University Hospital of Zürich, CH-8091 Zürich,
Switzerland
*Corresponding authors
Prion diseases are characterized by the deposition of
PrPSc, an abnormal form of the cellular prion protein
PrPC, which is encoded by the Prnp gene. PrPC is
highly expressed on neurons and its function is un-
known. Recombinant PrPC was claimed to possess
superoxide dismutase (SOD) activity, and it was hy-
pothesized that abrogation of this function may con-
tribute to neurodegeneration in prion diseases. We
tested this hypothesis in vivo by studying copper/zinc
and manganese SOD activity in genetically defined
crosses of mice lacking the Sod1 gene with mice
lacking PrPC, and with hemizygous or homozygous
tga20 transgenic mice overexpressing various levels
of PrPC. We failed to detect any influence of the Prnp
genotype and gene dosage on SOD1 or SOD2 activity
in heart, spleen, brain, and synaptosome-enriched
brain fractions. Control experiments included cross-
es of mice lacking or overexpressing PrPC with mice
overexpressing human Cu2 +/Zn2 +-superoxide dismu-
tase, and confirmed that SOD enzymatic activity cor-
related exclusively with the gene dosage of bona fide
human or murine SOD. We conclude that PrPC in vivo
does not discernibly contribute to total SOD activity
and does not possess an intrinsic dismutase activity.
Key words: Prion disease /PrPC /SOD/Synaptosomes /
Transgenic mice.
Introduction
Prion diseases are lethal neurodegenerative disorders
that affect humans and a variety of animal species. They
include bovine spongiform encephalopathy (BSE) in
cattle, chronic wasting disease in mule deer and elk, and
Creutzfeldt-Jakob disease (CJD) in humans. The
causative agent is termed prion (Prusiner, 1982) and was
proposed to be identical with PrPSc, a pathological con-
former of the cellular protein PrPc encoded by the Prnp
gene (Oesch et al., 1985; Basler et al., 1986). PrPC is a
glycosyl-phosphatidylinositol (GPI)-anchored glycopro-
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ent assays, we were not able to detect any PrPC-depend-
ent modulation of SOD activity in heart, spleen, liver,
brain as well as in synaptosome-enriched brain fractions.
We conclude that a direct or indirect contribution of PrPC
to SOD activity in these organs, at least under physiolog-
ical conditions, appears to be unlikely.
Results and Discussion
The current study was undertaken to test whether PrPC
modulates the total SOD activity in mouse tissues in vivo.
Formally, PrPC may alter SOD activity, because (i) it pos-
sesses intrinsic dismutase activity, or (ii) because it mod-
ifies, directly or indirectly, the activity of the endogenous
SOD1 enzyme – for example by altering copper metabo-
lism. Finally (iii), PrPC may conceivably modify by un-
known mechanisms, the activity and/or the tissue distri-
bution of the mitochondrial SOD2 enzyme. 
In order to prove or disprove each one of these hy-
potheses in vivo, we determined SOD1 and SOD2 activi-
ties in various crosses of mice lacking the Prnp and/or
Sod1 genes with mice transgenic for murine Prnp and for
the human copper-zinc SOD, hSod1. Transgenic Sod1–/–;
Prnpo/o and Sod1–/–;Prnpo/o;tga20+/– or Sod1–/–;Prnpo/o;
tga20+/+ mice were obtained by intercrossing Sod–/– mice
(Ho et al., 1998) with tga20 mice (Fischer et al., 1996)
which overexpress PrPC (Figure 1A). For control experi-
ments, we intercrossed transgenic mice overexpressing
the human SOD1 gene, hSod1 (Epstein et al., 1987), with
tga20 mice. Genotypes were screened by PCR analysis
(Figure 1B–E) and confirmed by assessing the presence
or absence of the proteins of interest by Western blot
(SOD1, MnSOD, PrPC), as well as functionally by analyz-
ing SOD1 and SOD2 enzyme activity (Figure 2). Double
and triple transgenic mice obtained in these crossings
did not show obvious phenotypic alterations, except for
mice homozygous for a disrupted SOD1 allele that exhib-
ited reduced fertility, as described earlier (Ho et al., 1998).
All mice developed normally, had a normal life expectan-
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Fig. 1 Breeding Strategy Depicted by a Pedigree (A) and PCR-Based Mouse Genotyping (B-E).
(A) Mice lacking SOD while expressing wild-type levels of PrPC (Sod–/–;Prnp+/+; Ho et al., 1998) were intercrossed with tga20 mice that
transgenically express PrPC under the control of the Prnp promoter on a Prnp-deficient background leading to an overexpression of
PrPC in all tissues (Fischer et al., 1996) while displaying wild-type levels of SOD1 (Sod1+/+;Prnpo/o;tga20+/+). The F1-generation was in-
tercrossed with each other to obtain the indicated genotypes in the F2-generation. (B) Mouse genotypes were identified by PCR analy-
sis. The Prnp-status was revealed by a PCR using three primers within the same reaction (see Materials and Methods), resulting in a
362 bp band for the neo-cassette and a larger 546 bp band for Prnp+. (C) Specific primers were used for detecting the tga20 transgene
resulting in a 740 bp band. (D) Presence of the Sod+ wild-type allele was confirmed by a 182 bp band which is abolished in SOD1–/–-
mice. The Sod– allele was demonstrated by an amplicon of 770 bp displaying the exon 4/neo cassette of the targeted Sod1-locus,
whereas in (E) the human hSod1 transgene was revealed by a band of 573 bp. (B-E) Respective genotypes of mice are indicated and a
100 bp DNA ladder (Boehringer, Rotkreuz, Switzerland) is shown on the left. Numbers on the right indicate respective size of the PCR
amplicons.
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cy (>350 days at the time of writing) and did not show his-
tological abnormalities in brain, spleen, liver, kidney and
heart (data not shown). 
Next, we evaluated SOD activity in brain, spleen, liver
and heart of mice expressing varying amounts of PrPC.
Using the xanthine/xanthine oxidase formazan based
SOD assay, we were not able to detect any difference in
total SOD activity between brain homogenates of Prnpo/o,
wild-type, and tga20 mice which lack, express physio-
logical amounts of, or overexpress PrPC, respectively
(Figure 3A, B). These results are in line with those ob-
tained by Waggoner and colleagues (2000). In addition,
we were not able to detect any SOD activity other than
SOD2 in mice overexpressing PrPC but lacking SOD1
(Sod–/–;tga20+/– or Sod–/–;tga20+/+; Figure 3A-D). This indi-
cates that PrPC, even when expressed at supraphysio-
logical levels, does not exhibit any intrinsic SOD activity
in vivo. Similar results to those in brain (Figure 3A, B) were
obtained in heart (Figure 3C, D), spleen (Figure 3E) and
liver (data not shown), consistently and regardless of
whether samples were analyzed in kinetic (Figure 3A, B,
E) or endpoint mode (Figure 3C, D), in which decrease in
the reaction speed or inhibition of formazan production
are plotted, respectively. 
Inhibition of SOD1 activity by KCN revealed no de-
tectable levels of MnSOD in brain (Figure 3B), liver, and
spleen of any of the mice investigated (data not shown)
and confirmed the specificity of the assay. In contrast,
MnSOD was readily detectable in mitochondria-rich
heart homogenates and, similar to SOD1, appeared to be
independent of PrPC-expression levels (Fig 3C, D). Multi-
ple independent experiments and use of alternative ho-
mogenization buffers and procedures (0.5% NP-40 and
0.5% DOC or sonication followed by ultracentrifugation
at 78 000 g for 30 min) as described earlier (Ewing and
Janero, 1995) produced the same results (data not
shown). An additional, independent SOD assay based on
auto-oxidation (Nebot et al., 1993) yielded identical re-
sults (Figure 3F). Repeated measurements confirmed
that the latter assay was robust and highly reproducible
with control material and all experimental samples (data
not shown). 
The highest concentration of PrPC is found in synapto-
some-enriched subcellular fractions, leading to specula-
tions that PrPC may serve as a copper buffer in the synap-
tic cleft (Brown et al., 1997a; Kretzschmar et al., 2000).
We therefore assayed the SOD activity of synaptosome-
enriched brain fractions of mice of all the genotypes de-
scribed above. In order to confirm the presence of SOD1
and of PrPC in crude synaptosomal brain fractions,
aliquots of each sample were subjected to Western blot
analysis in addition to SOD activity assays (Figure 4A).
Again, and in flagrant contrast to other reports (Brown
and Besinger, 1998; Brown et al., 1999; Milhavet et al.,
2000; Wong et al., 2000; Brown et al., 2002; Klamt et al.,
2001; Milhavet and Lehmann, 2002) we did not find any
contribution of PrPC to the overall SOD activity, nor did
we detect any intrinsic SOD activity of PrPC in crude
synaptosomal brain fractions (Figure 4B). 
Our results indicate that modulation of PrPC levels
does not influence the SOD activity in a series of tissues,
including brain. The data presented here were collected
from organs of genetically defined mouse models lacking
or expressing various levels of PrPC in the presence or
absence of endogenous SOD1, whereas most data de-
posing in favor an SOD activity of PrPC were recorded
with recombinant proteins. In addition, the xanthine-xan-
thine oxidase based assay (Okado-Matsumoto and
Fridovich, 2001) used in this study may be more sensitive
and less error-prone than the NBT-method mainly used in
previous studies (Brown et al., 1997b, 1999; Brown and
Besinger, 1998; Milhavet et al., 2000; Wong et al., 2000).
The NBT assay was shown to potentially interfere with
xanthine oxidase (Ukeda et al., 1997) and resulted in a
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Fig. 2 SOD Activity in Peripheral Blood and Protein Expression
in Spleen Homogenates.
(A) A non-denaturing gel-electrophoresis of peripheral blood
was performed resulting in mouse/mouse homodimers (mouse
SOD) migrating above hemoglobin (Hb), mouse/human het-
erodimers co-migrating with hemoglobin and a strong band of
human homodimeric SOD1 (human SOD1) below hemoglobin in
transgenic mice expressing hSOD1. Respective genotypes of
mice are indicated. (B) Western blot analysis of spleen ho-
mogenates of various mouse genotypes, as indicated, revealing
the expression, overexpression or absence of SOD1, MnSOD
and PrPC, as shown on the left. The human SOD1-band migrates
slightly slower and exhibits a strong band due to its overexpres-
sion in transgenic hSod1 mice. Equal loading is demonstrated
by developing membranes with an anti-β-actin antibody (lower
panel). Molecular mass in kDa is indicated on the right.
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poor reproducibility in our hands. While PrPC or peptides
thereof might exhibit a SOD1-mimetic function under
rather artificial settings in vitro, our results indicate that in
vivo a contribution of PrPC to the SOD activity or a direct
SOD-like function of PrPC, at least under physiological
conditions, appears to be unlikely. Certainly, it cannot be
excluded that PrPC merely under conditions of stress ex-
hibits a SOD-like function and, consequently, abrogation
of PrPC, e.g. in the course of prion disease, where PrPC is
converted into PrPSc, might be causally linked to in-
creased free radical formation and thus accelerate neu-
rodegeneration. This scenario, however, appears to be
less likely, since SOD1-activity levels and SOD1 protein
expression are not decreased in brains of scrapie-infect-
1282 G. Hutter et al.
Fig. 3 SOD Activity in Brain, Spleen and Heart Homogenates.
(A) Kinetic measurement of WST-Formazan reduction in a xanthine-xanthine oxidase based SOD-assay at 450 nm over 30 min at 37°C
displaying no significant difference in brain homogenates of mice lacking or overexpressing PrPC (lanes 4 – 6). No significant SOD-activ-
ity was measurable in mice lacking SOD1 (lanes 1 – 2), even when PrPC was overexpressed (lane 2). As positive control mice overex-
pressing the human SOD1 (lane 3) were used yielding high SOD levels. (B) KCN-inhibition of same samples as in (A) resulting in a com-
plete inhibition of SOD1, thus displaying MnSOD activity. While the MnSOD enzyme was present in brain extracts (see Figure 2B), its
activity even on a SOD1–/–-background (lanes 1 – 2) could not be detected in brain, spleen (not shown) and liver (not shown) samples.
Merely a residual SOD1 activity in transgenic hSod1 mice was detectable, since 15 mM KCN were not sufficient to completely abolish hu-
man SOD1 overexpression. Values are indicated as vmax in mOD/min in the linear range of the assay. (C) and (D) indicate percent inhibition
of WST-Formazan reduction in a xanthine-xanthine oxidase based SOD-assay with an endpoint measurement at 450 nm in heart ho-
mogenates yielding similar results as in (A). In mitochondria-rich heart fractions, MnSOD is readily detectable upon adding 15 mM KCN at
similar levels independent of the level of PrPC expression. (E) Kinetic measurement of WST-formazan reduction in a xanthine-xanthine ox-
idase based SOD-assay in spleen homogenates also displays no contribution of PrPC to the SOD-activity (lanes 4 and 5) or an intrinsic
SOD-like activity in the absence of SOD1 (lane 2 vs. 1). Again, mice overexpressing the human SOD1 (lane 3) served as positive control.
(F) Similarly as in the formazan based assay (see 3A), no SOD-like activity of PrPC in brain homogenates was detectable when a SOD-as-
say was used that is based on auto-oxidation. (A-F) Six different mouse genotypes are displayed in lanes 1 – 6. Lane 1: Sod1–/–;-Prnpo/o,
lane 2: Sod1–/–;Prnpo/o;tga20+/+, lane 3: hSod1+/–;Prnp+/o;tga20+/–, lane 4: Sod1+/+;Prnpo/o, lane 5: Sod1+/+;Prnpo/o;tga20+/+, lane 6:
Sod1+/+;Prnp+/+, lane 7: water or buffer (blank). Several independent experiments were performed of which one representative is shown.
Experiments were performed in triplicate and mean value ± standard deviation is depicted. 
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ed hamsters (Choi et al., 1998) and mice (Lee et al., 1999).
In addition, we were also not able to detect any alteration
of SOD1 protein levels in terminally scrapie-sick mouse
brains (G.H., F.L.H. and A.A., unpublished observations). 
The negative results reported here certainly do not
negate a role for reactive oxygen species in prion patho-
genesis. Oxidative stress may play a role in a variety of
neurodegenerative diseases (Perry et al., 2002). It will
therefore be interesting to test whether absence or over-
expression of SOD1 alters susceptibility of mice to prion
infection, and to assess the capability of mice lacking
SOD1 to cope with oxidative stress in the presence or ab-
sence of PrPC. 
Materials and Methods 
Generation and Genotyping of Transgenic Mice
Prnpo/o (Büeler et al., 1992) and tga20 mice (Fischer et al., 1996)
were intercrossed with Sod1–/– mice lacking the endogenous
SOD1 protein (Ho et al., 1998; Figure 1A), or with transgenic
hSod1 mice (Epstein et al., 1987) which overexpress the human
SOD1 protein. The following genotypes were obtained and used
for further analysis: (i) Sod1–/–;Prnpo/o, (ii) Sod1–/–;Prnpo/o;tga20+/–
or Sod1–/–;Prnpo/o;tga20+/+, (iii) hSod+/–;Prnpo/o, (iv) hSod+/–;Prnpo/o;
tga20+/– or hSod+/–;Prnpo/o;tga20+/+. As controls, the following lit-
termates were used: (v) Sod1+/+;Prnpo/o, (vi) Sod1+/+;Prnp+/+ and
(vii) Sod1+/+;Prnpo/o;tga20+/+. 
All genotypes were confirmed by PCR analysis of tail DNA
(Figure 1B-D). The following primers were used: Detection of the
Prnp+ and Prnpo alleles using 3 primers within the same PCR re-
action as described (Fischer et al., 1996): (5’ ATT CGC AGC GCA
TCG CCT TCT ATC GCC 3’), (5’ GTA CCC ATA ATC AGT GGA
ACA AGC CCA GC 3’), (5’ CCC TCC CCC AGC CTA GAC CAC
GA 3’). Detection of the transgenic tga20+ allele: (5’ CAA CCG
AGC TGA AGC ATT CTG CCT 3’), (5’ CCT GGG ACT CCT TCT
GGT ACC GGG TGA CGC 3’). Detection of the transgenic hSod1
allele: (5’ TGG GTA TTG TTG GGA GGA GG 3’), (5’ TCT GTT CCA
CTG AAG CTG TT 3’). Detection of the Sod+ allele by amplifying
exon 5 of the murine Sod1-locus which is removed in the Sod1–/–
mice by targeted disruption (Ho et al., 1998): (5’ CTT GAT CAT
TCA AAC CTA AAT GTT CTT 3’), (5’ CAG TTG AGT CTG AGA
CTT CAG ACC ACA 3’). Detection of the Sod– allele by amplify-
ing the exon 4/neo cassette in Sod1–/– mice (Ho et al., 1998):
(5’ GAA CAT CGT GTG ATC TCA CTC TCA GGA GAG 3’), (5’ AAA
AGC GCC TCC CCT ACC CGG TAG AAT TGA 3’).
Non-Denaturing Gel-Electrophoresis and SOD Zymography
To confirm functionally the presence or absence of endogenous
SOD and/or transgenic human Cu2 +/Zn2 +-superoxide dismutase
(hSOD1) activity, erythrocytes were subjected to non-denaturing
gel-electrophoresis as described (Beauchamp and Fridovich,
1971). Erythrocytes were lysed, loaded on a non-denaturing gel,
and electrophoresed. Gels were stained with 1 mg/ml nitro-blue
tetrazolium (NBT) for 20 min and thereafter soaked in 0.036 M
potassium phosphate buffer (all reagents were purchased from
Sigma Inc., Buchs, Switzerland, unless otherwise specified),
pH 7.8, containing 10 µg/ml riboflavin and 3 µl/ml TEMED. Gen-
eration of superoxide radicals was induced by subjecting the
gels to ultraviolet light resulting in reduction of NBT. Areas with
SOD activity remained unstained due to superoxide dismutation
(Figure 2A). 
Histological Analysis
Mice were deeply anaesthetized, and brain, heart, liver and
spleen were removed and fixed in 4% paraformaldehyde in PBS.
After embedding the organs in paraffin, tissue was processed
according to standard procedures and routinely stained with
hematoxylin and eosin (H&E; data not shown).
Preparation of Synaptosome-Enriched Brain Fractions
Synaptosome-enriched brain fractions were prepared according
to a protocol provided by Dr. Lloyd Vaughan (Veterinary Patholo-
gy, University of Zürich, Zürich, Switzerland). Mice were deeply
anaesthetized and brains were removed. Next, brain tissue was
cut into small pieces with a razor blade and homogenized by a
teflon/glass homogenizer (12 strokes) in 10 volumes of ice-cold
buffered sucrose (320 mM sucrose, 4 mM HEPES, pH 7.4) sup-
plemented with a protease inhibitor cocktail (1 tablet per 10 ml
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Fig. 4 Protein Expression and SOD Activity in Synaptosome-
Enriched Brain Fractions.
(A) Western blot analysis of crude synaptosomal brain fractions
of mouse genotypes, as indicated, consisting of synaptophysin-
positive material (synapto, upper panel) displaying SOD1- and
PrPC-protein in the respective samples. (B) Same samples as
depicted in (A) were subjected to WST-formazan reduction in a
xanthine-xanthine oxidase based SOD-assay with an endpoint
measurement at 450 nm. Percent inhibition of WST-formazan
reduction of crude synaptosomes is illustrated. Again, no contri-
bution of PrPC to the overall SOD activity (lanes 5 – 7), nor a SOD-
like activity of PrPC, even when overexpressed, was detectable
in the absence of endogenous SOD1 (lanes 1 – 2). Synaptosomal
fractions of mice overexpressing human SOD1 served as posi-
tive controls (lanes 2 – 3). Two independent experiments were
performed of which one representative is displayed. Each ex-
periment was performed in triplicate and mean value ± standard
deviation is depicted.
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homogenate; Roche, Rotkreuz, Switzerland). Thereafter, homo-
genates were centrifuged for 10 min at 1100 g at 4°C. Super-
natant was transferred to a new tube and centrifuged for 15 min
at 9200 g at 4°C for a second time. The pellet was resuspended
in 10 ml ice-cold buffered sucrose and centrifuged once more
for 15 min at 10 500 g at 4°C. The resulting pellet consisting of
crude synaptosomes was then used for Western blot analysis or
for SOD assays. 
SOD Assays
Mice were deeply anaesthetized and perfused with ice-cold PBS
(pH 7.4) in order to remove blood cells. Brain, liver, spleen and
heart were excised, snap-frozen in liquid nitrogen, and stored at
– 80°C until further use. Samples were weighed and thawed in
ice-cold 50 mM phosphate buffer (pH 7.4) containing a pro-
teinase inhibitor cocktail (1 tablet per 10 ml homogenate;
Roche). Samples were homogenized with a Polytron tissue
grinder, and crude homogenates were centrifuged at 15 000 g
for 30 min at 4°C. Supernatant was then analyzed by a standard
BCA assay (Pierce, Rockford, USA) to determine protein con-
centration. All samples were then adjusted to the same concen-
tration. 
Three different SOD assays were used to analyze SOD and
SOD-mimetic activity: First, a xanthine/xanthine-oxidase based
assay (Dojindo Molecular Technologies) was performed accord-
ing to the manufacturer’s instruction. This assay utilizes the sodi-
um salt of 4-[3-(4iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-
1,3-benzene disulfonate, a water-soluble tetrazolium (WST), as a
detector of superoxide radical generation (Peskin and Winter-
bourn, 2000). The assay was standardized by measuring SOD
activity of bovine erythrocytes (data not shown). Selective inhibi-
tion of SOD1 activity in Sod1+/+-Prnp+/+ mice was achieved by
adding 15 mM potassium cyanide (KCN) for 30 min on ice, thus
allowing to assess the activity of the manganese SOD (MnSOD
or SOD2). Lower doses of KCN, in contrast to other reports
(Okado-Matsumoto and Fridovich, 2001), did not result in com-
plete inhibition of SOD1 in our experimental series. Two µg of to-
tal protein were analyzed per reaction; experiments were run in
triplicates and analyzed in a 96-well plate reader (SpectraMax,
Molecular Devices Corporation, Sunnyvale, USA). Upon appli-
cation of the enzyme solution, the linear increase of absorption
at 450 nm was monitored constantly over 30 min in kinetic or
endpoint mode at 37°C. Inhibition of formazan production was
plotted against corresponding blank controls. 
The second SOD assay is based on the SOD-mediated in-
crease in the rate of autoxidation of 5,6,6a,11b-tetrahydro-
3,9,10-trihydroxybenzo[c]fluorene in aqueous alkaline solution,
which generates a chromophore with a wavelength of maximal
absorbance at 525 nm (Nebot et al., 1993). The assay was per-
formed according to the instructions of the manufacturer (Cal-
biochem, San Diego, USA). Tissue extracts were prepared as
described above, and 250 µl homogenate with a concentration
of 5 µg/µl of total protein were subjected to ethanol/chloroform
(67.5/32.5 v/v) extraction. Thereafter, 40 µl of supernatant were
incubated with the assay reagents as described according to the
manufacturer’s instructions. Absorption at 525 nm and 37°C
was monitored for 5 min. Increase of absorption per time of dif-
ferent samples in the linear range of the assay was plotted. All ki-
netic and endpoint data were processed automatically by the
SOFTMax Pro software (SpectraMax).
Thirdly, we attempted to establish an NBT-based assay using
the non-enzymatic superoxide generator phenazine methosul-
fate in combination with NADH (Ewing and Janero, 1995). Sam-
ples were prepared as described above. Additionally, sonication
of the extract and/or treatment with 0.5% DOC and 0.5% NP-40
followed by ultracentrifugation (78 000 g, 30 min) was per-
formed. However, we experienced poor reproducibility and vari-
ability in repeated measurements of the same probes; therefore
this assay was excluded from further analyses. 
Western Blots
Aliquots of the same tissue homogenates as used for SOD as-
says were run on SDS-PAGE gels (5% stacking and 16% resolv-
ing) and transferred on nitrocellulose (Schleicher & Schuell, Das-
sel, Germany) by wet blotting. Membranes were blocked with
5% Top-Block (Juro, Luzern, Switzerland) in Tris-buffered saline-
Tween (TBS-T) at room temperature (RT) for 1 hour and, there-
after, incubated for one hour at RT with the primary antibody di-
luted in 1% Top-Block in TBS-T. As primary antibody we used an
anti-PrP antibody (ICSM18; kind gift of Dr. S. Hawke, London,
UK; dilution 1:30 000), an anti-SOD1 antibody (Calbiochem; di-
lution 1:1 000: approximately 16 kDa), an anti-SOD2 antibody
(Stressgen, Victoria, Canada; dilution 1:5 000; approx. 25 KDa)
or an anti-β-actin antibody (Jackson, USA; dilution 1: 5 000).
Membranes were washed three times for 15 min in TBS-T, and
incubated for further 45 minutes with a horseradish peroxidase
(HRP)-labeled secondary antibody diluted in 1% Top-Block in
TBS-T. As secondary antibody we used rabbit-anti-mouse IgG1-
HRP (Zymed, South San Francisco, USA, dilution 1:10 000) for
detecting anti-PrP and anti-β-actin antibodies or goat-anti-
sheep IgG-HRP for detecting anti-SOD1 and anti-SOD2 anti-
bodies (Jackson; dilution 1:10 000). Membranes were washed
three times for 15 min in TBS-T and developed using enhanced
chemiluminescence (ECL, Pierce) detection reagents. 
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